The Antiemetics Market is expected to register a CAGR of 5.8% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the antiemetics market is segmented by drug type into serotonin receptor antagonists, dopamine antagonists, antihistamines, and others. Applications analyzed include chemotherapy-induced nausea and vomiting (CINV), motion sickness, post-operative nausea, and others. End-users include hospitals, clinics, and retail pharmacies. Regional coverage includes North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses.
Purpose of the ReportThe report Antiemetics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antiemetics Market Segmentation
Drug Class- 5-HT3 Receptor Antagonists
- NK1 Receptor Antagonist
- Dopamine Antagonists
- Antihistamines
- Cannabinoids
- Benzodiazepines
- Corticosteroids
- Anticholinergic
- Chemotherapy-Induced Nausea and Vomiting
- Gastroenteritis
- Nausea and Vomiting of Pregnancy
- Post-Operative Nausea and Vomiting
Strategic Insights
Antiemetics Market Growth Drivers- Increasing Incidence of Gastrointestinal Diseases: The increasing incidence of gastrointestinal diseases like gastroenteritis, irritable bowel syndrome, and peptic ulcers is an important factor for the demand for antiemetics. The World Gastroenterology Organisation states that gastrointestinal diseases have affected more than 30% of the global population, and symptoms include nausea and vomiting. The increasing consumption of processed and unhealthy foods, along with a sedentary lifestyle, increases these conditions. This increases the amount of demand for antiemetic drugs that will solve gastrointestinal problems momentarily.
- Increasing chemotherapy treatments: Treatment procedures of cancers, mainly chemotherapy, cause extreme nausea and vomiting in the patients. According to the American Cancer Society, more than 18 million new cases of cancer are diagnosed every year worldwide; most such patients are going through chemotherapy. As a result, there has been an ongoing demand for antiemetic drugs that can provide an effective quality of life for patients suffering from cancer. Big pharmaceutical houses are increasing their research efforts to make available targeted therapies that minimize CINV.
- Increased Global Travel and Motion Sickness Cases: Along with the rapid increase in international travels, motion sickness has become an important issue related to traveling people. Long journeys undertaken by sea, roads, and aeroplanes increase nausea and vomiting, and in turn, encourage the use of OTC antiemetic medication. The IATA reported 70% of global passenger air traffic over the last decade to further emphasize motion sickness medications. The availability of chewable tablets and dissolvable strips has made it easier for consumers to manage symptoms during travel.
- Preference for Natural and Herbal Antiemetics:
Consumers are moving towards natural and herbal solutions for nausea control due to fears over synthetic drug side effects. Ginger, peppermint, and chamomile are all well-known for their antiemetic properties. According to the American Botanical Council, sales of herbal supplements for digestive health, including antiemetics, have risen by 15% annually. Pharmaceutical companies are launching herbal-based formulations to meet this increasing demand. This is more powerful in health-aware consumers looking to take preventive health care measures.
- Advances in Technologies for Drug Delivery Systems:
Innovative drug delivery technologies like fast-dissolving tablets, transdermal patches, and oral films make the treatment process for antiemetic agents more efficient and convenient. They allow quicker absorption of drugs while offering extended periods of relief. In this sense, the pharmaceutical firms are spending considerable research in innovative drug delivery formats aimed at the specific patient requirements, that is, the pediatric and geriatric population, thereby contributing to future growth prospects in the market.
- Rising Adoption of Telemedicine and E-Prescriptions:
The popularity of telemedicine services makes it easier to reach antiemetic drugs and, therefore access to such drugs from the patients becomes easy. In the digital world, remote consultancy and e-prescriptions are quite easy, that increase the patients' convenience for healthcare services. The COVID-19 pandemic created an environment by emphasizing the benefits of virtual healthcare, thereby accelerating this trend. Such companies are reaching agreements with providers of telemedicine to expand markets and ensure no barriers in providing antiemetics.
- Focus on pediatric and geriatric-friendly formulations:
Specialized formulations for children and the aged will create a huge market. Most of these age groups have different physiological requirements or may face difficulties due to conventional drug forms. From flavored syrups and chewable tablets, pediatric-friendly formulas are becoming popular, and soft variants for the elderly are also in demand. Companies that can provide products specifically designed for these categories of consumers will get larger share in the market. - Growing investments in R&D for cancer supportive care:
With the increasing number of cancer cases, pharmaceutical companies are investing heavily in R&D to develop more effective antiemetic solutions for cancer patients. Breakthrough therapies that address chemotherapy-induced nausea and vomiting (CINV) are emerging as a focus area. Combination therapies that offer enhanced efficacy are expected to revolutionize cancer supportive care. - E-Commerce Channels for OTC Medications:
Increasing online pharmacies have become a big commercial potential for antiemetic product sales. E-commerce portals allow consumers to buy drugs from the comfort of their homes, sitting in their pyjamas. Companies which are able to strengthen their online and digital presence and leverage e-commerce portals are likely to capitalize on this significant trend in the online delivery of healthcare services. The key will be partnerships with leading e-pharmacies and targeted digital marketing.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antiemetics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antiemetics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antiemetics Market is expected to register a CAGR of 5.8% from 2025-2031.
The major driving factors supporting the Antiemetics market growth are - Increasing Incidence of Gastrointestinal Diseases, Increasing Chemotherapy Treatments, Increased Global Travel and Motion Sickness Cases
Key future trends in the Antiemetics Market are - Preference for Natural and Herbal Antiemetics, Advances in Technologies for Drug Delivery Systems, Rising Adoption of Telemedicine and E-Prescriptions
Key companies in the Antiemetics Market are- Abbott, Dr. Reddy's Laboratories Ltd., Aphios Corporation, Aurobindo Pharma, Merck Sharp and Dohme Corp, Eisai Co., Ltd, Glaxosmithkline Plc, Helsinn Healthcare SA, Heron Therapeutics, Inc, Sun Pharmaceutical Industries Ltd
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiemetics Market - By Drug Class
1.3.2 Antiemetics Market - By Application
1.3.3 Antiemetics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIEMETICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ANTIEMETICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIEMETICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIEMETICS - GLOBAL MARKET OVERVIEW
6.2. ANTIEMETICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIEMETICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. 5-HT3 RECEPTOR ANTAGONISTS
7.3.1. Overview
7.3.2. 5-HT3 Receptor Antagonists Market Forecast and Analysis
7.4. NK1 RECEPTOR ANTAGONIST
7.4.1. Overview
7.4.2. NK1 Receptor Antagonist Market Forecast and Analysis
7.5. DOPAMINE ANTAGONISTS
7.5.1. Overview
7.5.2. Dopamine Antagonists Market Forecast and Analysis
7.6. ANTIHISTAMINES
7.6.1. Overview
7.6.2. Antihistamines Market Forecast and Analysis
7.7. CANNABINOIDS
7.7.1. Overview
7.7.2. Cannabinoids Market Forecast and Analysis
7.8. BENZODIAZEPINES
7.8.1. Overview
7.8.2. Benzodiazepines Market Forecast and Analysis
7.9. CORTICOSTEROIDS
7.9.1. Overview
7.9.2. Corticosteroids Market Forecast and Analysis
7.10. ANTICHOLINERGIC
7.10.1. Overview
7.10.2. Anticholinergic Market Forecast and Analysis
8. ANTIEMETICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
8.3.1. Overview
8.3.2. Chemotherapy-Induced Nausea and Vomiting Market Forecast and Analysis
8.4. GASTROENTERITIS
8.4.1. Overview
8.4.2. Gastroenteritis Market Forecast and Analysis
8.5. NAUSEA AND VOMITING OF PREGNANCY
8.5.1. Overview
8.5.2. Nausea and Vomiting of Pregnancy Market Forecast and Analysis
8.6. POST-OPERATIVE NAUSEA AND VOMITING
8.6.1. Overview
8.6.2. Post-Operative Nausea and Vomiting Market Forecast and Analysis
9. ANTIEMETICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antiemetics Market Overview
9.1.2 North America Antiemetics Market Forecasts and Analysis
9.1.3 North America Antiemetics Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antiemetics Market Forecasts and Analysis - By Application
9.1.5 North America Antiemetics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antiemetics Market
9.1.5.1.1 United States Antiemetics Market by Drug Class
9.1.5.1.2 United States Antiemetics Market by Application
9.1.5.2 Canada Antiemetics Market
9.1.5.2.1 Canada Antiemetics Market by Drug Class
9.1.5.2.2 Canada Antiemetics Market by Application
9.1.5.3 Mexico Antiemetics Market
9.1.5.3.1 Mexico Antiemetics Market by Drug Class
9.1.5.3.2 Mexico Antiemetics Market by Application
9.2. EUROPE
9.2.1 Europe Antiemetics Market Overview
9.2.2 Europe Antiemetics Market Forecasts and Analysis
9.2.3 Europe Antiemetics Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antiemetics Market Forecasts and Analysis - By Application
9.2.5 Europe Antiemetics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antiemetics Market
9.2.5.1.1 Germany Antiemetics Market by Drug Class
9.2.5.1.2 Germany Antiemetics Market by Application
9.2.5.2 France Antiemetics Market
9.2.5.2.1 France Antiemetics Market by Drug Class
9.2.5.2.2 France Antiemetics Market by Application
9.2.5.3 Italy Antiemetics Market
9.2.5.3.1 Italy Antiemetics Market by Drug Class
9.2.5.3.2 Italy Antiemetics Market by Application
9.2.5.4 Spain Antiemetics Market
9.2.5.4.1 Spain Antiemetics Market by Drug Class
9.2.5.4.2 Spain Antiemetics Market by Application
9.2.5.5 United Kingdom Antiemetics Market
9.2.5.5.1 United Kingdom Antiemetics Market by Drug Class
9.2.5.5.2 United Kingdom Antiemetics Market by Application
9.2.5.6 Rest of Europe Antiemetics Market
9.2.5.6.1 Rest of Europe Antiemetics Market by Drug Class
9.2.5.6.2 Rest of Europe Antiemetics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antiemetics Market Overview
9.3.2 Asia-Pacific Antiemetics Market Forecasts and Analysis
9.3.3 Asia-Pacific Antiemetics Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antiemetics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Antiemetics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antiemetics Market
9.3.5.1.1 Australia Antiemetics Market by Drug Class
9.3.5.1.2 Australia Antiemetics Market by Application
9.3.5.2 China Antiemetics Market
9.3.5.2.1 China Antiemetics Market by Drug Class
9.3.5.2.2 China Antiemetics Market by Application
9.3.5.3 India Antiemetics Market
9.3.5.3.1 India Antiemetics Market by Drug Class
9.3.5.3.2 India Antiemetics Market by Application
9.3.5.4 Japan Antiemetics Market
9.3.5.4.1 Japan Antiemetics Market by Drug Class
9.3.5.4.2 Japan Antiemetics Market by Application
9.3.5.5 Rest of Asia-Pacific Antiemetics Market
9.3.5.5.1 Rest of Asia-Pacific Antiemetics Market by Drug Class
9.3.5.5.2 Rest of Asia-Pacific Antiemetics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antiemetics Market Overview
9.4.2 Middle East and Africa Antiemetics Market Forecasts and Analysis
9.4.3 Middle East and Africa Antiemetics Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antiemetics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Antiemetics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antiemetics Market
9.4.5.1.1 South Africa Antiemetics Market by Drug Class
9.4.5.1.2 South Africa Antiemetics Market by Application
9.4.5.2 Saudi Arabia Antiemetics Market
9.4.5.2.1 Saudi Arabia Antiemetics Market by Drug Class
9.4.5.2.2 Saudi Arabia Antiemetics Market by Application
9.4.5.3 U.A.E Antiemetics Market
9.4.5.3.1 U.A.E Antiemetics Market by Drug Class
9.4.5.3.2 U.A.E Antiemetics Market by Application
9.4.5.4 Rest of Middle East and Africa Antiemetics Market
9.4.5.4.1 Rest of Middle East and Africa Antiemetics Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Antiemetics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antiemetics Market Overview
9.5.2 South and Central America Antiemetics Market Forecasts and Analysis
9.5.3 South and Central America Antiemetics Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antiemetics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Antiemetics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antiemetics Market
9.5.5.1.1 Brazil Antiemetics Market by Drug Class
9.5.5.1.2 Brazil Antiemetics Market by Application
9.5.5.2 Argentina Antiemetics Market
9.5.5.2.1 Argentina Antiemetics Market by Drug Class
9.5.5.2.2 Argentina Antiemetics Market by Application
9.5.5.3 Rest of South and Central America Antiemetics Market
9.5.5.3.1 Rest of South and Central America Antiemetics Market by Drug Class
9.5.5.3.2 Rest of South and Central America Antiemetics Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTIEMETICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. DR. REDDY'S LABORATORIES LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. APHIOS CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AUROBINDO PHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK SHARP AND DOHME CORP
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. EISAI CO., LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HELSINN HEALTHCARE SA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. HERON THERAPEUTICS, INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SUN PHARMACEUTICAL INDUSTRIES LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
1. Abbott
2. Dr. Reddy's Laboratories Ltd.
3. Aphios Corporation
4. Aurobindo Pharma
5. Merck Sharp and Dohme Corp
6. Eisai Co., Ltd
7. Glaxosmithkline Plc
8. Helsinn Healthcare SA
9. Heron Therapeutics, Inc
10. Sun Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For